A decreasing trend of body fat was observed in the Metformin-XR group, but it slightly fluctuated in the DLBS3233 group.
← all excerpts
The Efficacy and Safety of DLBS3233, A Combined Bioactive Fraction of <i>Cinnamomum burmanii</i> and <i>Lagerstroemia</i> speciosa Plants on The Endocrine-Metabolic Profile of Women with Polycystic Ovary Syndrome: A Randomized Clinical Trial.
1
—
—